Page 1583 - Small Animal Internal Medicine, 6th Edition

Index 1555

Diabetes mellitus (Continued) Diet (Continued) Diltiazem (Continued) Doberman Pinschers
hyperadrenocorticism and, 874–875 elemental, 437 in cats, 90t–91t chronic hepatitis in, 584–586
hypertension and, 830 elimination, 434 in dogs, 90t–91t dilated cardiomyopathy in, 141–142
VetBooks.ir in cats, 830 for enteral support, 437 heart rate control using, 129 Dobutamine, 62b
wobbler syndrome in, 1153f
insulin-dependent
dosage of, 90t–91t
enteral, 436t
fiber-enriched, 435
Docosahexaenoic acid, 72–73
for left ventricular outflow tract
in dogs, 809
insulin-resistant, 753, 830
obstruction, 167
912t
non-insulin-dependent, 809 hypertriglyceridemia managed with, pharmacokinetics of, 96 DOCP, 887–888
Dofetilide, 96
Diabetic ketoacidosis, 840–847 hypoallergenic, 434b Dimethyl sulfoxide (DMSO), 683 Dog
bicarbonate therapy for, 842b, 844–845 iodine-restricted, 796t, 797–798 Dioctophyma renale, 669–670 clinical conditions of, 990–1006
clinical features of, 840–841 management, 434–437 Dioctyl sodium sulfosuccinate, 445t, balanoposthitis in, 992–993, 993f
clinicopathologic abnormalities parenteral nutrition, 437 515t–517t cryptorchidism in, 990–991, 991f
associated with, 843b partially hydrolyzed, 435 Dipentum. see Olsalazine paraphimosis in, 993–996, 994f
complications of, 847 ultra-low-fat, 435 Diphenhydramine, 386t–388t, 515t–517t, persistent penile frenulum in, 992,
concurrent illness for, 846 veterinary therapeutic, 904, 904t–906t 1185t–1186t 992f
diagnosis of, 841 weight loss through, 904t–906t Diphenoxylate, 440, 440t phimosis in, 993–996
etiology of, 840 Dietary options, 903 2,3-Diphosphoglycerate, 1353–1354, priapism in, 993–996, 994f–996f
fluid therapy for, 842–845, 842b Dietary supplements, 73 1360 scrotal dermatitis in, 992, 992f
insulin therapy for, 842b, 845–846 Dietary-induced acute diarrhea, 475–476 Dipylidium caninum, 1537 testicular neoplasia in, 996–997,
magnesium supplementation for, 844 Dietary-responsive large intestinal Direct antiglobulin test, 1216, 1216b 996f–997f
phosphate supplementation for, diarrhea, 494 Direct Coombs test, 1233–1234, testicular torsion in, 991, 991f
843–844 Dietary-responsive small intestinal 1349–1350 urethral prolapse in, 992
potassium supplementation for, 843 diarrhea, 491–492 Direct current cardioversion, for liver diseases in, 585t
treatment of, 841–846 Diethylstilbestrol (DES), 732–735, ventricular tachyarrhythmias, 84 myocardial diseases in, 141–157
Diabetic nephropathy, 829 733t–734t, 959, 982 Dirofilaria immitis, 1249 Dog bites, 1539–1542
Diabetic neuropathy Diffuse splenomegaly, 1409–1410 Dirofilaria immitis Dog erythrocyte antigen (DEA), 1351,
in cats, 839–840 Diffuse thickening of the laryngeal life cycle of, 193 1360–1361
in dogs, 829 mucosa, 276 lung disease caused by, 344 Dolasetron, 438
Diabetic polyneuropathy, 1164, 1165f Digestion microfilaria identification tests, Dopamine, for atrioventricular
Diabinese. see Chlorpropamide diagnostic tests for, 423 195–196 conduction block, 88
Dialysis, for acute kidney injury, 692 fecal tests for evaluating, 399, 413–414 in urine sediment, 669–670 Dopamine agonists, 955
Diaphragm, of stethoscope, 7 Digestive enzyme supplementation, 440 Disappearing bile duct syndrome, Dopaminergic compounds, for
Diaphragmatic hernia Digoxin, 62b 598–599 pregnancy termination, 960
peritoneopericardial, 174–175, antiarrhythmic effects of, 69 Discospondylitis, 1440t Dopaminergic receptors, 691
175f–176f atrial fibrillation treated with, 85 Disinfection protocols, 1450 Doppler echocardiography, 27–32
traumatic causes of, 362–363 chronic heart failure treated with, 64t, Diskospondylitis, 1143–1144, color flow mapping, 31–32, 31f–32f
Diarrhea 69–70 1143f–1144f continuous wave, 30, 31f
acute, 398–399, 398b, 474–476 contraindications, 69 Disseminated intravascular coagulation hypertrophic cardiomyopathy, 152,
acute enteritis, 474–475 dilated cardiomyopathy treated with, clinical features of, 1401–1402 164f
dietary-induced, 475–476 145 complications of, 1404 infective endocarditis, 136, 136f
enterotoxemia and, 475 electrocardiographic changes definition of, 1400–1401 pressure gradient estimation, 30–31
chronic, 399, 399t associated with, 49b diagnosis of, 1402–1403, 1403t pulsed wave, 28–30, 29f–30f
definition of, 398–402 heart rate control using, 129 heartworm disease as cause of, 197 Doppler tissue imaging, 32, 32f
dietary-responsive large intestinal, 494 pharmacokinetics of, 72 hemostatic abnormalities associated Dorsal vulvar hooding, 982f
endoparasitism and, 1028 serum concentrations of, 69–70 with, 1402, 1402t Dorsoventral bands, 936–937
fiber-enriched diets for, 435 toxicity caused by, 70, 147 heparin for, 1403 Dorsoventral view, 14
fiber-responsive large bowel, 494 Digoxin-immune Fab, 70 intravascular coagulation cessation, Dostinex. see Cabergoline
infectious, 476–480 1,25-Dihydroxycholecalciferol, 695–696 1403–1404 Doubling time, 1269
canine coronaviral enteritis, 479 1,25-Dihydroxy-vitamin D 3 (calcitriol), parenchymal organ perfusion in, 1404 Doxorubicin
canine parvoviral enteritis, 476–478, 765–766 pathogenesis of, 1404 cardiotoxicity induced by, 150, 170,
477b Dilated cardiomyopathy, 141–148 primary disorders associated with, 1283–1284
elokomin fluke fever, 480 in cats, 169–171 1400–1404, 1402t dosage of, 1327b
feline coronaviral enteritis, 479 chronic therapy for, 170 prognosis for, 1404 enterocolitis induced by, 1281
feline immunodeficiency in dogs splenic torsion as cause of, 1413 tissue necrosis caused by, 1282f
virus-associated diarrhea, 480 atrial fibrillation associated with, symptomatic, 1401 Doxycycline, 386t–388t, 515t–517t
feline leukemia virus- 141 thrombocytopenia caused by, 1241t acute bacterial upper respiratory
panleukopenia-like syndrome, breeds commonly affected, 141 treatment of, 1403–1404, 1403b infection treated with, 1444
479–480 cardiac chamber dilation associated Disseminated toxoplasmosis, 1522 bacterial infections treated with,
feline parvoviral enteritis, 478–479 with, 142 Distemper meningoencephalitis, 1125 1437t–1438t
salmon poisoning, 480 clinical findings of, 142 Distemper virus, canine, 1485–1487 bartonellosis treated with, 1457–1458
large intestinal, 399t, 401b clinicopathologic findings, 144–145 clinical features of, 1485–1486, 1486t canine chronic bronchitis treated with,
motility modifiers for, 440–441, 440t diagnosis of, 142–144, 143f diagnosis of, 1125, 1486–1487 328
small intestinal, 399t, 400f echocardiographic findings, 144, etiology of, 1485 canine monocytotropic ehrlichiosis
Diastole, 8 144f medallion lesions from, 1486f treated with, 1476
Diastolic dysfunction electrocardiographic findings, myocarditis in puppies caused by, feline bronchitis treated with, 332–333
chronic, 73 142–144 153 rickettsial polyarthritis treated with,
heart failure caused by, 65 etiology of, 141–142 pathogenesis of, 1485 1200
Diastolic murmurs, 9, 11 idiopathic, 141 prevention of, 1487 Rocky Mountain spotted fever treated
Diazepam, 62b, 386t–388t, 1104, long term therapy for, 146–147, 146b signs of, 1124 with, 1480
1185t–1186t monitoring of, 147 treatment of, 1487 toxicity caused by, 1439t
Diazoxide therapy, 850b, 852 pathophysiology of, 141–142 vaccination for, 1454–1455 Wolbachia pipientis treated with, 198
Dibenzyline. see Phenoxybenzamine primary, 141 zoonotic aspects of, 1487 Dried solidified blood calculi, 722, 722f
Diestrus, 938t, 939–940, 940f, 949, prognosis of, 147–148 Ditropan. see Oxybutynin Droncit. see Praziquantel
955–956 radiographic findings, 142, 143f Diuresis, for heart failure, 61 Drontal Plus. see Pyrantel/febantel/
Diet, 434 sudden death caused by, 147–148 Diuretics praziquantel
bland, 434, 434b treatment of, 145 acute kidney injury treated with, 691 Drooling, 389–391, 390b
for calcium oxalate urolithiasis, ventricular premature complexes chronic congestive heart failure treated Drug toxicities, electrocardiographic
717–718, 718b and, 142 with, 66–67 changes associated with, 47–48, 49b
chronic heart failure managed echocardiographic findings, 170 loop Drugs. see also specific drug
through, 72–73 occult, 145 acute kidney injury treated with, for cardiovascular disorders,
for chronic hepatitis, in dogs, 590, pimobendan for, 145 691 235t–239t
591t taurine deficiency and, 73, 170 chronic heart failure treated with, for chronic hepatitis, in dogs, 590–595
for chronic kidney disease, 699–702 treatment of, 145, 170–171 66–67 for electrolyte disorders, 934t
diabetes mellitus managed with Diltiazem, 73 pulmonary edema caused by, 382 for endocrine disorders, 896t–897t
in cats, 834–835 adverse effects of, 96 thiazide, 67 for hepatobiliary and pancreatic
in dogs, 816, 816b atrial fibrillation treated with, 84–85 Diuril. see Chlorothiazide disorders, 643t–648t